222 related articles for article (PubMed ID: 10026446)
1. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
Imamura M; Hosotani R; Kogire M
Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
[TBL] [Abstract][Full Text] [Related]
2. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Masao K; Kabuto T; Furukawa H; Imaoka S
Hepatogastroenterology; 1998; 45(21):644-50. PubMed ID: 9684110
[TBL] [Abstract][Full Text] [Related]
6. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
Sho M; Murakami Y; Motoi F; Satoi S; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Kurata M; Fukumoto T; Akahori T; Kinoshita S; Nagai M; Nishiwada S; Unno M; Yamaue H; Nakajima Y
J Gastroenterol; 2015 Jun; 50(6):694-702. PubMed ID: 25341657
[TBL] [Abstract][Full Text] [Related]
7. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?].
Böttger T; Boddin J; Küchle R; Junginger T
Langenbecks Arch Chir; 1997; 382(4):209-15. PubMed ID: 9445967
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
9. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.
Fortner JG; Klimstra DS; Senie RT; Maclean BJ
Ann Surg; 1996 Feb; 223(2):147-53. PubMed ID: 8597508
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic hepatic irradiation following curative resection of pancreatic cancer.
Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Inoue K; Katano S; Tsukiyama I
J Hepatobiliary Pancreat Surg; 2005; 12(3):235-42. PubMed ID: 15995813
[TBL] [Abstract][Full Text] [Related]
11. Unexpected Para-aortic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: a Contraindication to Resection?
Kim JS; Hwang HK; Lee WJ; Kang CM
J Gastrointest Surg; 2020 Dec; 24(12):2789-2799. PubMed ID: 31792906
[TBL] [Abstract][Full Text] [Related]
12. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T
J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
Carr JA; Ajlouni M; Wollner I; Wong D; Velanovich V
Am Surg; 1999 Dec; 65(12):1143-9. PubMed ID: 10597062
[TBL] [Abstract][Full Text] [Related]
14. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil.
Foo ML; Gunderson LL; Nagorney DM; McLlrath DC; van Heerden JA; Robinow JS; Kvols LK; Garton GR; Martenson JA; Cha SS
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):483-9. PubMed ID: 8390422
[TBL] [Abstract][Full Text] [Related]
15. Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.
Tani M; Kawai M; Miyazawa M; Hirono S; Ina S; Nishioka R; Fujita Y; Uchiyama K; Yamaue H
Langenbecks Arch Surg; 2009 Mar; 394(2):249-53. PubMed ID: 18343944
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
17. [Factors influencing the long-term survival in pancreatic carcinoma patients after radical resection].
Zhang WJ; Han SL; Jiang FZ; Zhu HL; Ye BL; Ke QH; Fang Y
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):870-2. PubMed ID: 19173836
[TBL] [Abstract][Full Text] [Related]
18. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Furukawa H; Kabuto T; Kameyama M; Nakamori S; Hiratsuka M; Imaoka S
Am J Surg; 1994 Oct; 168(4):361-4. PubMed ID: 7943597
[TBL] [Abstract][Full Text] [Related]
19. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
20. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
